• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对支出增长进行分解后发现,在1980年至2006年期间,治疗的年度成本对支出增长的贡献最大。

Decomposing growth in spending finds annual cost of treatment contributed most to spending growth, 1980-2006.

作者信息

Starr Martha, Dominiak Laura, Aizcorbe Ana

出版信息

Health Aff (Millwood). 2014 May;33(5):823-31. doi: 10.1377/hlthaff.2013.0656.

DOI:10.1377/hlthaff.2013.0656
PMID:24799580
Abstract

Researchers have disagreed about factors driving up health care spending since the 1980s. One camp, led by Kenneth Thorpe, identifies rising numbers of people being treated for chronic diseases as a major factor. Charles Roehrig and David Rousseau reach the opposite conclusion: that three-quarters of growth in average spending reflects the rising costs of treating given diseases. We reexamined sources of spending growth using data from four nationally representative surveys. We found that rising costs of treatment accounted for 70 percent of growth in real average health care spending from 1980 to 2006. The contribution of shares of the population treated for given diseases increased in 1997-2006, but even then it accounted for only one-third of spending growth. We highlight the fact that Thorpe's inclusion of population growth as part of disease prevalence explains the appreciable difference in results. An important policy implication is that programs to better manage chronic diseases may only modestly reduce average spending growth.

摘要

自20世纪80年代以来,研究人员对于推动医疗保健支出上升的因素一直存在分歧。以肯尼斯·索普为首的一派认为,慢性病治疗人数的增加是一个主要因素。查尔斯·勒里希和大卫·卢梭则得出了相反的结论:平均支出增长的四分之三反映了治疗特定疾病成本的上升。我们使用来自四项全国代表性调查的数据重新审视了支出增长的来源。我们发现,治疗成本的上升占1980年至2006年实际平均医疗保健支出增长的70%。特定疾病治疗人群比例的贡献在1997年至2006年有所增加,但即便如此,它在支出增长中所占比例也仅为三分之一。我们强调这样一个事实,即索普将人口增长纳入疾病流行率的一部分,这解释了结果中存在的明显差异。一个重要的政策含义是,更好地管理慢性病的项目可能只会适度降低平均支出增长。

相似文献

1
Decomposing growth in spending finds annual cost of treatment contributed most to spending growth, 1980-2006.对支出增长进行分解后发现,在1980年至2006年期间,治疗的年度成本对支出增长的贡献最大。
Health Aff (Millwood). 2014 May;33(5):823-31. doi: 10.1377/hlthaff.2013.0656.
2
The Role of Chronic Disease, Obesity, and Improved Treatment and Detection in Accounting for the Rise in Healthcare Spending Between 1987 and 2011.慢性病、肥胖以及治疗与检测水平的提高在解释1987年至2011年医疗支出增长方面所起的作用。
Appl Health Econ Health Policy. 2015 Aug;13(4):381-7. doi: 10.1007/s40258-015-0164-7.
3
Factors accounting for the rise in health-care spending in the United States: the role of rising disease prevalence and treatment intensity.美国医疗保健支出增长的影响因素:疾病患病率上升和治疗强度的作用。
Public Health. 2006 Nov;120(11):1002-7. doi: 10.1016/j.puhe.2006.09.001. Epub 2006 Oct 9.
4
Treated disease prevalence and spending per treated case drove most of the growth in health care spending in 1987-2009.在 1987 年至 2009 年期间,医疗保健支出的增长主要归因于治疗疾病的患病率和每个治疗病例的支出。
Health Aff (Millwood). 2013 May;32(5):851-8. doi: 10.1377/hlthaff.2012.0391.
5
Rising medicare costs: are we in crisis?不断上涨的医疗保险费用:我们正处于危机之中吗?
Health Aff (Millwood). 2006 Sep-Oct;25(5):w389-90; discussion w391-2. doi: 10.1377/hlthaff.25.w389. Epub 2006 Aug 22.
6
The growth in cost per case explains far more of US health spending increases than rising disease prevalence.每例成本的增长解释了美国医疗支出增长的原因,远比疾病流行率上升的原因要多。
Health Aff (Millwood). 2011 Sep;30(9):1657-63. doi: 10.1377/hlthaff.2010.0644.
7
Which medical conditions account for the rise in health care spending?哪些医疗状况导致了医疗保健支出的增加?
Health Aff (Millwood). 2004 Jul-Dec;Suppl Web Exclusives:W4-437-45. doi: 10.1377/hlthaff.w4.437.
8
Health care costs: market forces and reform.医疗保健成本:市场力量与改革
Stat Bull Metrop Insur Co. 1995 Jan-Mar;76(1):29-35.
9
Health spending projections through 2019: the recession's impact continues.2019 年之前的卫生支出预测:经济衰退的影响仍在持续。
Health Aff (Millwood). 2010 Mar-Apr;29(3):522-9. doi: 10.1377/hlthaff.2009.1074. Epub 2010 Feb 4.
10
The value of medical spending in the United States, 1960-2000.1960年至2000年美国医疗支出的价值。
N Engl J Med. 2006 Aug 31;355(9):920-7. doi: 10.1056/NEJMsa054744.

引用本文的文献

1
What is driving 340B growth: utilization or price?推动340B增长的因素是什么:利用率还是价格?
Health Aff Sch. 2025 May 21;3(6):qxaf104. doi: 10.1093/haschl/qxaf104. eCollection 2025 Jun.
2
Twenty-year trend in comorbidity score among adults aged 50-85 years in Lombardy, Italy: Age-Cohort-Period analysis and future trends.意大利伦巴第地区50 - 85岁成年人共病评分的20年趋势:年龄-队列-时期分析及未来趋势
BMJ Open. 2025 Apr 10;15(4):e097385. doi: 10.1136/bmjopen-2024-097385.
3
How to Predict Drug Expenditure: A Markov Model Approach with Risk Classes.
如何预测药物支出:基于风险类别的马尔可夫模型方法。
Pharmacoeconomics. 2023 May;41(5):561-572. doi: 10.1007/s40273-023-01240-3. Epub 2023 Feb 25.
4
Health Care Spending on Respiratory Diseases in the United States, 1996-2016.美国 1996-2016 年呼吸系统疾病医疗支出。
Am J Respir Crit Care Med. 2023 Jan 15;207(2):183-192. doi: 10.1164/rccm.202202-0294OC.
5
What is the major driver of China's hospital medical expenditure growth? A decomposing analysis.中国医院医疗支出增长的主要驱动因素是什么?一项分解分析。
BMJ Open. 2022 Feb 8;12(2):e048308. doi: 10.1136/bmjopen-2020-048308.
6
Factors related to the change in Swiss inpatient costs by disease: a 6-factor decomposition.疾病相关的瑞士住院费用变化因素:6 因素分解。
Eur J Health Econ. 2021 Mar;22(2):195-221. doi: 10.1007/s10198-020-01243-3. Epub 2021 Jan 12.
7
Attributing medical spending to conditions: A comparison of methods.归因于医疗支出的条件:方法比较。
PLoS One. 2020 Aug 10;15(8):e0237082. doi: 10.1371/journal.pone.0237082. eCollection 2020.
8
Factors Contributing to the Rising National Cost of Glucose-Lowering Medicines for Diabetes During 2005-2007 and 2015-2017.2005-2007 年和 2015-2017 年期间导致糖尿病降血糖药物国家费用上升的因素。
Diabetes Care. 2020 Oct;43(10):2396-2402. doi: 10.2337/dc19-2273. Epub 2020 Jul 31.
9
Decomposition Analysis of Spending and Price Trends for Biologic Antirheumatic Drugs in Medicare and Medicaid.医疗保险和医疗补助中生物类抗风湿药物的支出和价格趋势分解分析。
Arthritis Rheumatol. 2020 Feb;72(2):234-241. doi: 10.1002/art.41138. Epub 2020 Jan 6.
10
Decomposing changes in the growth of U.S. prescription drug use and expenditures, 1999-2016.剖析 1999-2016 年美国处方药使用和支出增长的变化。
Health Serv Res. 2019 Aug;54(4):752-763. doi: 10.1111/1475-6773.13164. Epub 2019 May 9.